Sette A - Search Results

1

Human CTL epitopes encoded by human papillomavirus type 16 E6 and E7 identified through in vivo and in vitro immunogenicity studies of HLA-A*0201-binding peptides.

Ressing ME, Sette A, Brandt RM, Ruppert J, Wentworth PA, Hartman M, Oseroff C, Grey HM, Melief CJ, Kast WM. Ressing ME, et al. Among authors: sette a. J Immunol. 1995 Jun 1;154(11):5934-43. J Immunol. 1995. PMID: 7538538

2

Role of HLA-A motifs in identification of potential CTL epitopes in human papillomavirus type 16 E6 and E7 proteins.

Kast WM, Brandt RM, Sidney J, Drijfhout JW, Kubo RT, Grey HM, Melief CJ, Sette A. Kast WM, et al. Among authors: sette a. J Immunol. 1994 Apr 15;152(8):3904-12. J Immunol. 1994. PMID: 7511661

3

The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes.

Sette A, Vitiello A, Reherman B, Fowler P, Nayersina R, Kast WM, Melief CJ, Oseroff C, Yuan L, Ruppert J, Sidney J, del Guercio MF, Southwood S, Kubo RT, Chesnut RW, Grey HM, Chisari FV. Sette A, et al. J Immunol. 1994 Dec 15;153(12):5586-92. J Immunol. 1994. PMID: 7527444

4

HLA-DR3 molecules can bind peptides carrying two alternative specific submotifs.

Geluk A, van Meijgaarden KE, Southwood S, Oseroff C, Drijfhout JW, de Vries RR, Ottenhoff TH, Sette A. Geluk A, et al. Among authors: sette a. J Immunol. 1994 Jun 15;152(12):5742-8. J Immunol. 1994. PMID: 8207204

5

Occasional memory cytotoxic T-cell responses of patients with human papillomavirus type 16-positive cervical lesions against a human leukocyte antigen-A *0201-restricted E7-encoded epitope.

Ressing ME, van Driel WJ, Celis E, Sette A, Brandt MP, Hartman M, Anholts JD, Schreuder GM, ter Harmsel WB, Fleuren GJ, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: sette a. Cancer Res. 1996 Feb 1;56(3):582-8. Cancer Res. 1996. PMID: 8564975

6

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes.

Alexander J, Oseroff C, Sidney J, Wentworth P, Keogh E, Hermanson G, Chisari FV, Kubo RT, Grey HM, Sette A. Alexander J, et al. Among authors: sette a. J Immunol. 1997 Nov 15;159(10):4753-61. J Immunol. 1997. PMID: 9366399

7

Detection of T helper responses, but not of human papillomavirus-specific cytotoxic T lymphocyte responses, after peptide vaccination of patients with cervical carcinoma.

Ressing ME, van Driel WJ, Brandt RM, Kenter GG, de Jong JH, Bauknecht T, Fleuren GJ, Hoogerhout P, Offringa R, Sette A, Celis E, Grey H, Trimbos BJ, Kast WM, Melief CJ. Ressing ME, et al. Among authors: sette a. J Immunother. 2000 Mar-Apr;23(2):255-66. doi: 10.1097/00002371-200003000-00010. J Immunother. 2000. PMID: 10746552

8

Overcoming T cell tolerance to the hepatitis B virus surface antigen in hepatitis B virus-transgenic mice.

Sette AD, Oseroff C, Sidney J, Alexander J, Chesnut RW, Kakimi K, Guidotti LG, Chisari FV. Sette AD, et al. J Immunol. 2001 Jan 15;166(2):1389-97. doi: 10.4049/jimmunol.166.2.1389. J Immunol. 2001. PMID: 11145724

9

Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules.

Sette A, Vitiello A, Farness P, Furze J, Sidney J, Claverie JM, Grey HM, Chesnut R. Sette A, et al. J Immunol. 1991 Dec 1;147(11):3893-900. J Immunol. 1991. PMID: 1658152

10

Inhibition of experimental autoimmune encephalomyelitis induction in SJL/J mice by using a peptide with high affinity for IAs molecules.

Lamont AG, Sette A, Fujinami R, Colón SM, Miles C, Grey HM. Lamont AG, et al. Among authors: sette a. J Immunol. 1990 Sep 15;145(6):1687-93. J Immunol. 1990. PMID: 1697306

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,098 results

Search Page